145 related articles for article (PubMed ID: 6369667)
1. Fatal central nervous system infection with varicella-zoster virus in renal transplant recipients.
Peterson LR; Ferguson RM
Transplantation; 1984 Apr; 37(4):366-8. PubMed ID: 6369667
[TBL] [Abstract][Full Text] [Related]
2. Acyclovir therapy of varicella-zoster virus infections in immunocompromised patients.
Balfour HH; McMonigal KA; Bean B
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():169-79. PubMed ID: 6313596
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and outcome of herpes zoster infection in renal transplant recipients.
Kırnap M; Akdur A; Ayvazoğlu Soy HE; Arslan H; Yıldırım S; Moray G; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():280-3. PubMed ID: 25894173
[TBL] [Abstract][Full Text] [Related]
4. Natural history and treatment of varicella-zoster in high-risk populations.
Gnann JW; Whitley RJ
J Hosp Infect; 1991 Jun; 18 Suppl A():317-29. PubMed ID: 1679798
[TBL] [Abstract][Full Text] [Related]
5. Successful combination therapy with acyclovir and vidarabine for disseminated varicella zoster virus infection with retinal involvement in a patient with B-cell lymphoma and adult T-cell leukemia.
Moriyama K; Asano Y; Fujimoto K; Okamura T; Shibuya T; Harada M; Niho Y
Am J Med; 1988 Dec; 85(6):885-6. PubMed ID: 3264113
[No Abstract] [Full Text] [Related]
6. Antiviral treatment in chickenpox and herpes zoster.
Huff JC
J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):204-6. PubMed ID: 3339143
[TBL] [Abstract][Full Text] [Related]
7. Comparison of acyclovir and vidarabine in immunocompromised children with varicella-zoster virus infection.
Kunitomi T; Akazai A; Ikeda M; Oda M; Kodani N
Acta Paediatr Jpn; 1989 Dec; 31(6):702-5. PubMed ID: 2516397
[TBL] [Abstract][Full Text] [Related]
8. Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group.
Whitley RJ; Gnann JW; Hinthorn D; Liu C; Pollard RB; Hayden F; Mertz GJ; Oxman M; Soong SJ
J Infect Dis; 1992 Mar; 165(3):450-5. PubMed ID: 1538151
[TBL] [Abstract][Full Text] [Related]
9. SIADH during disseminated Herpes varicella-zoster infections: relationship to vidarabine therapy.
Semel JD; McNerney JJ
Am J Med Sci; 1986 Feb; 291(2):115-8. PubMed ID: 3946467
[TBL] [Abstract][Full Text] [Related]
10. Comparative trial of acyclovir and vidarabine in disseminated varicella-zoster virus infections in immunocompromised patients.
Vildé JL; Bricaire F; Leport C; Renaudie M; Brun-Vézinet F
J Med Virol; 1986 Oct; 20(2):127-34. PubMed ID: 3534140
[TBL] [Abstract][Full Text] [Related]
11. Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine.
Shepp DH; Dandliker PS; Meyers JD
N Engl J Med; 1986 Jan; 314(4):208-12. PubMed ID: 3001523
[TBL] [Abstract][Full Text] [Related]
12. Varicella zoster virus encephalitis in solid organ transplant recipients: Case series and review of literature.
Kang M; Aslam S
Transpl Infect Dis; 2019 Apr; 21(2):e13038. PubMed ID: 30548548
[TBL] [Abstract][Full Text] [Related]
13. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
Balfour HH
Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
[TBL] [Abstract][Full Text] [Related]
14. CNS diseases associated with varicella zoster virus and herpes simplex virus infection. Pathogenesis and current therapy.
Barnes DW; Whitley RJ
Neurol Clin; 1986 Feb; 4(1):265-83. PubMed ID: 3523204
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic approaches to varicella-zoster virus infections.
Whitley RJ
J Infect Dis; 1992 Aug; 166 Suppl 1():S51-7. PubMed ID: 1378081
[TBL] [Abstract][Full Text] [Related]
16. Current therapy of varicella zoster virus infection in immunocompromised patients. A comparison of acyclovir and vidarabine.
Shepp DH; Dandliker PS; Meyers JD
Am J Med; 1988 Aug; 85(2A):96-8. PubMed ID: 3044102
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of varicella zoster virus infection following allogeneic stem cell transplants].
Doki N; Hoshino T; Irisawa H; Sakura T; Miyawaki S
Rinsho Ketsueki; 2004 Oct; 45(10):1090-4. PubMed ID: 15553042
[TBL] [Abstract][Full Text] [Related]
18. Varicella zoster virus infections in immunocompromised hosts. A review of the natural history and management.
Balfour HH
Am J Med; 1988 Aug; 85(2A):68-73. PubMed ID: 3044096
[TBL] [Abstract][Full Text] [Related]
19. Varicella zoster virus reactivation in hemodialysis patients: manifestations, treatment, complications and outcome.
Mesar I; Basić-Jukić N; Hudolin T; Katalinić L; Kes P
Acta Clin Croat; 2011 Dec; 50(4):549-52. PubMed ID: 22649885
[TBL] [Abstract][Full Text] [Related]
20. Unusual neurologic manifestations of varicella zoster virus infection with the absence of rash in a kidney transplant recipient.
Assi M; Abou Antoun S
Transpl Infect Dis; 2011 Oct; 13(5):545-7. PubMed ID: 21338462
[No Abstract] [Full Text] [Related]
[Next] [New Search]
